glp 1 diabetes treatment How GLP-1 medications are transforming and weight loss GLP-1 Drugs: Fighting Diabetes and

Measurable changes in body composition (fat mass reduction via DEXA or bioimpedance analysis) typically become apparent at 46 weeks when paired with consistent caloric deficit

Simon LE, Rajendra Kumar T, Duncan FE

Yes, IGF-1 LR3 has a more targeted action on muscle cells, making it superior for localized muscle hypertrophy compared to HGHs systemic effects

There is a significant loss of rods by 5 weeks of age (P35), around the time when cone degeneration begins, making evaluation of cone function by photopic b-wave ERG a desirable output for protecting photoreceptor survival with benchmarks at P35, P50 and P65 [9]